QUZYTTIR
These highlights do not include all the information needed to use QUZYTTIR™ safely and effectively. See full prescribing information for QUZYTTIR™.QUZYTTIR™ (cetirizine hydrochloride injection), for intravenous use Initial U.S. Approval: 1995
Approved
Approval ID
f33e859d-ebc9-4d4f-a57d-204c48760d20
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 25, 2022
Manufacturers
FDA
TerSera Therapeutics LLC
DUNS: 080226115
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cetirizine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70720-100
Application NumberNDA211415
Product Classification
M
Marketing Category
C73594
G
Generic Name
Cetirizine Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 27, 2020
FDA Product Classification
INGREDIENTS (5)
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT
cetirizine hydrochlorideActive
Quantity: 10 mg in 1 mL
Code: 64O047KTOA
Classification: ACTIB
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT